Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Antibacterial and Hypoglycemic Diterpenoids from Salvia chamaedryoides.

Bisio A, De Mieri M, Milella L, Schito AM, Parricchi A, Russo D, Alfei S, Lapillo M, Tuccinardi T, Hamburger M, De Tommasi N.

J Nat Prod. 2017 Feb 24;80(2):503-514. doi: 10.1021/acs.jnatprod.6b01053. Epub 2017 Feb 10.

PMID:
28186413
2.

Establishment and analysis of in vitro biomass from Salvia corrugata Vahl. and evaluation of antimicrobial activity.

Bisio A, Fraternale D, Schito AM, Parricchi A, Dal Piaz F, Ricci D, Giacomini M, Ruffoni B, De Tommasi N.

Phytochemistry. 2016 Feb;122:276-285. doi: 10.1016/j.phytochem.2015.12.017. Epub 2016 Jan 2.

PMID:
26753532
3.

Antibacterial compounds from Salvia adenophora Fernald (Lamiaceae).

Bisio A, Schito AM, Ebrahimi SN, Hamburger M, Mele G, Piatti G, Romussi G, Dal Piaz F, De Tommasi N.

Phytochemistry. 2015 Feb;110:120-32. doi: 10.1016/j.phytochem.2014.10.033. Epub 2014 Nov 27.

PMID:
25435172
4.

A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation.

Parodi B, Russo E, Caviglioli G, Baldassari S, Gaglianone N, Schito AM, Cafaggi S.

Drug Dev Ind Pharm. 2013 Dec;39(12):1911-20. doi: 10.3109/03639045.2012.694589. Epub 2012 Jun 8.

PMID:
22681543
5.

Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.

Schito AM, Piatti G, Stauder M, Bisio A, Giacomelli E, Romussi G, Pruzzo C.

Int J Antimicrob Agents. 2011 Feb;37(2):129-34. doi: 10.1016/j.ijantimicag.2010.10.016. Epub 2010 Dec 15.

PMID:
21163629
6.

Quinolone/fluoroquinolone susceptibility in Escherichia coli correlates with human polymicrobial bacteriuria and with in vitro interleukine-8 suppression.

Saverino D, Schito AM, Mannini A, Penco S, Bassi AM, Piatti G.

FEMS Immunol Med Microbiol. 2011 Feb;61(1):84-93. doi: 10.1111/j.1574-695X.2010.00751.x. Epub 2010 Nov 10.

7.

Antiadhesion and antibiofilm activities of high molecular weight coffee components against Streptococcus mutans.

Stauder M, Papetti A, Mascherpa D, Schito AM, Gazzani G, Pruzzo C, Daglia M.

J Agric Food Chem. 2010 Nov 24;58(22):11662-6. doi: 10.1021/jf1031839. Epub 2010 Nov 1.

PMID:
21038921
8.

Antimicrobial activity of the ornamental species Salvia corrugata, a potential new crop for extractive purposes.

Bisio A, Romussi G, Russo E, Cafaggi S, Schito AM, Repetto B, De Tommasi N.

J Agric Food Chem. 2008 Nov 26;56(22):10468-72. doi: 10.1021/jf802200x.

PMID:
18973336
9.

Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance.

Piatti G, Mannini A, Balistreri M, Schito AM.

J Clin Microbiol. 2008 Feb;46(2):480-7. Epub 2007 Dec 5.

10.

Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis.

Roveta S, Schito AM, Marchese A, Schito GC.

Int J Antimicrob Agents. 2007 Nov;30(5):415-21. Epub 2007 Sep 4.

PMID:
17768034
11.

In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.

Gualco L, Schito AM, Schito GC, Marchese A.

Int J Antimicrob Agents. 2007 Jun;29(6):679-87. Epub 2007 Mar 23.

PMID:
17363225
12.

Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.

Gualco L, Debbia EA, Bandettini R, Pescetto L, Cavallero A, Ossi MC, Schito AM, Marchese A.

Int J Antimicrob Agents. 2007 Feb;29(2):179-84. Epub 2006 Dec 18.

PMID:
17175140
13.

Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.

Roveta S, Schito AM, Marchese A, Schito GC.

Int J Antimicrob Agents. 2005 Nov;26(5):366-72. Epub 2005 Oct 7.

PMID:
16216467
14.

High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy.

Branca G, Spanu T, Cammarota G, Schito AM, Gasbarrini A, Gasbarrini GB, Fadda G.

Int J Antimicrob Agents. 2004 Nov;24(5):433-8.

PMID:
15519473
15.

In vitro activity of ertapenem against selected respiratory pathogens.

Marchese A, Gualco L, Schito AM, Debbia EA, Schito GC.

J Antimicrob Chemother. 2004 Nov;54(5):944-51. Epub 2004 Oct 7.

PMID:
15472001
16.

Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression.

Tavella S, Biticchi R, Schito A, Minina E, Di Martino D, Pagano A, Vortkamp A, Horton WA, Cancedda R, Garofalo S.

J Bone Miner Res. 2004 Oct;19(10):1678-88. Epub 2004 Jul 12.

17.

Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.

Schito AM, Schito GC.

J Chemother. 2004 Apr;16 Suppl 2:3-7. Review. No abstract available.

PMID:
15255554
18.
19.

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms.

Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM.

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:95-100.

PMID:
14527779
20.

In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance.

Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM.

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9.

PMID:
14527772
21.

Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation.

Barbieri O, Astigiano S, Morini M, Tavella S, Schito A, Corsi A, Di Martino D, Bianco P, Cancedda R, Garofalo S.

Am J Physiol Cell Physiol. 2003 Dec;285(6):C1504-12. Epub 2003 Aug 13.

22.

Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000.

Schito AM, Schito GC, Debbia E, Russo G, Liñares J, Cercenado E, Bouza E.

J Chemother. 2003 Jun;15(3):226-34.

PMID:
12868547
23.

Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy).

Duprè I, Zanetti S, Schito AM, Fadda G, Sechi LA.

J Med Microbiol. 2003 Jun;52(Pt 6):491-8.

PMID:
12748268
24.
25.

HHV 8 seroprevalence and transmission within Albanian family groups.

Graffeo R, Ranno S, Marchetti S, Capodicasa N, Schito AM, Fuga L, Amico R, Cattani P, Fadda G.

New Microbiol. 2003 Jan;26(1):1-6.

PMID:
12578305
26.

The Italian Epidemiological Survey 1997-1999. Antimicrobial susceptibility data of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis in Italy.

Nicoletti G, Blandino G, Caccamo F, Friscia O, Schito AM, Speciale A; Italian Epidemiologial Observatory.

Int J Antimicrob Agents. 2002 Oct;20(4):263-9.

PMID:
12385682
27.

Early detection of negative BACTEC MGIT 960 cultures by PCR-reverse cross-blot hybridization assay.

Romano L, Sanguinetti M, Posteraro B, Ardito F, Gesu G, Schito AM, Fadda G.

J Clin Microbiol. 2002 Sep;40(9):3499-501.

28.

Comparative activity of linezolid against staphylococci and enterococci isolated in Italy.

Stefani S, Mezzatesta ML, Tempera G, Debbra E, Schito AM, Nicoletti G, Marchére A.

Clin Microbiol Infect. 2002 Jun;8(6):368-72.

29.

Antibiotic prescribing for dental conditions: a community-based study in southern Italy.

Mazzaglia G, Arcoraci V, Blandino G, Miragliotta G, Schito AM, Pasquantonio G, Nicoletti G, Caputi AP.

J Chemother. 2002 Feb;14(1):65-70.

PMID:
11892902
30.

Antibiotic persistence: the role of spontaneous DNA repair response.

Debbia EA, Roveta S, Schito AM, Gualco L, Marchese A.

Microb Drug Resist. 2001 Winter;7(4):335-42.

PMID:
11822773
31.

Evolution of the CCR5 Delta32 mutation based on haplotype variation in Jewish and Northern European population samples.

Klitz W, Brautbar C, Schito AM, Barcellos LF, Oksenberg JR.

Hum Immunol. 2001 May;62(5):530-8.

PMID:
11334678
32.
33.

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group.

Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR.

Immunogenetics. 2000 Apr;51(4-5):281-8.

PMID:
10803840
34.

mRNA distribution in adult human brain of GRIN2B, a N-methyl-D-aspartate (NMDA) receptor subunit.

Schito AM, Pizzuti A, Di Maria E, Schenone A, Ratti A, Defferrari R, Bellone E, Mancardi GL, Ajmar F, Mandich P.

Neurosci Lett. 1997 Dec 12;239(1):49-53.

PMID:
9547169
35.

Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12.

Mandich P, Schito AM, Bellone E, Antonacci R, Finelli P, Rocchi M, Ajmar F.

Genomics. 1994 Jul 1;22(1):216-8.

PMID:
7959773
36.

Synthesis, antiviral (HSV-1) and antimycotic activities of ethyl or methyl 2,4-disubstituted 5-pyrimidinecarboxylates, 2,4-disubstituted 5-pyrimidinecarboxylic acids and 2,4-disubstituted pyrimidines.

Sansebastiano L, Mosti L, Menozzi G, Schenone P, Muratore O, Petta A, Debbia E, Schito AP, Schito GC.

Farmaco. 1993 Mar;48(3):335-55.

PMID:
8391820
37.

Preparation and antimicrobial activity of 1-arylazo-3,4,6,7,8,9-hexahydroquinolizines.

Sparatore A, Boido CC, Boido V, Sparatore F, Debbia E, Schito AP.

Farmaco. 1990 Jul;45(7-8):867-77.

PMID:
2282120

Supplemental Content

Loading ...
Support Center